Gavin P. Robertson - Publications

Affiliations: 
Pennsylvania State University, State College, PA, United States 
Area:
Cell Biology, Oncology

66 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Kuzu OF, Noory MA, Robertson GP. The Role of Cholesterol in Cancer. Cancer Research. 76: 2063-70. PMID 27197250 DOI: 10.1158/0008-5472.CAN-15-2613  1
2015 Kardos GR, Robertson GP. Therapeutic interventions to disrupt the protein synthetic machinery in melanoma. Pigment Cell & Melanoma Research. 28: 501-19. PMID 26139519 DOI: 10.1111/pcmr.12391  1
2015 Kardos GR, Wastyk HC, Robertson GP. Disruption of Proline Synthesis in Melanoma Inhibits Protein Production Mediated by the GCN2 Pathway. Molecular Cancer Research : McR. PMID 26082174 DOI: 10.1158/1541-7786.MCR-15-0048  1
2014 Gowda R, Madhunapantula SV, Sharma A, Kuzu OF, Robertson GP. Nanolipolee-007, a novel nanoparticle-based drug containing leelamine for the treatment of melanoma. Molecular Cancer Therapeutics. 13: 2328-40. PMID 25082958 DOI: 10.1158/1535-7163.MCT-14-0357  1
2014 Kardos GR, Dai MS, Robertson GP. Growth inhibitory effects of large subunit ribosomal proteins in melanoma. Pigment Cell & Melanoma Research. 27: 801-12. PMID 24807543 DOI: 10.1111/pcmr.12259  1
2014 Kuzu OF, Gowda R, Sharma A, Robertson GP. Leelamine mediates cancer cell death through inhibition of intracellular cholesterol transport. Molecular Cancer Therapeutics. 13: 1690-703. PMID 24688051 DOI: 10.1158/1535-7163.MCT-13-0868  1
2014 Gowda R, Madhunapantula SV, Kuzu OF, Sharma A, Robertson GP. Targeting multiple key signaling pathways in melanoma using leelamine. Molecular Cancer Therapeutics. 13: 1679-89. PMID 24688050 DOI: 10.1158/1535-7163.MCT-13-0867  1
2014 Dluzen DF, Sun D, Salzberg AC, Jones N, Bushey RT, Robertson GP, Lazarus P. Regulation of UDP-glucuronosyltransferase 1A1 expression and activity by microRNA 491-3p. The Journal of Pharmacology and Experimental Therapeutics. 348: 465-77. PMID 24399855 DOI: 10.1124/jpet.113.210658  1
2014 Mumford BS, Robertson GP. Circulating melanoma cells in the diagnosis and monitoring of melanoma: an appraisal of clinical potential. Molecular Diagnosis & Therapy. 18: 175-83. PMID 24297151 DOI: 10.1007/s40291-013-0071-2  1
2013 Gowda R, Jones NR, Banerjee S, Robertson GP. Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer Therapy. Journal of Nanomedicine & Nanotechnology. 4. PMID 25013742 DOI: 10.4172/2157-7439.1000184  1
2013 Madhunapantula SV, Sharma A, Gowda R, Robertson GP. Identification of glycogen synthase kinase 3α as a therapeutic target in melanoma. Pigment Cell & Melanoma Research. 26: 886-99. PMID 24034838 DOI: 10.1111/pcmr.12156  1
2013 Wang Y, Xu Z, Guo S, Zhang L, Sharma A, Robertson GP, Huang L. Intravenous delivery of siRNA targeting CD47 effectively inhibits melanoma tumor growth and lung metastasis. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1919-29. PMID 23774794 DOI: 10.1038/mt.2013.135  1
2013 Gallant JN, Matthew EM, Cheng H, Harouaka R, Lamparella NE, Kunkel M, Yang Z, Harvey HA, Cream LV, Kumar SM, Robertson GP, Zheng S, Drabick JJ, Truica CI, El-Deiry WS. Predicting therapy response in live tumor cells isolated with the flexible micro spring array device. Cell Cycle (Georgetown, Tex.). 12: 2132-43. PMID 23759587 DOI: 10.4161/cc.25165  1
2013 Sharma A, Madhunapantula SV, Gowda R, Berg A, Neves RI, Robertson GP. Identification of aurora kinase B and Wee1-like protein kinase as downstream targets of (V600E)B-RAF in melanoma. The American Journal of Pathology. 182: 1151-62. PMID 23416158 DOI: 10.1016/j.ajpath.2012.12.019  1
2013 Evans MS, Madhunapantula SV, Robertson GP, Drabick JJ. Current and future trials of targeted therapies in cutaneous melanoma. Advances in Experimental Medicine and Biology. 779: 223-55. PMID 23288642 DOI: 10.1007/978-1-4614-6176-0_10  1
2013 Gowda R, Madhunapantula SV, Desai D, Amin S, Robertson GP. Simultaneous targeting of COX-2 and AKT using selenocoxib-1-GSH to inhibit melanoma. Molecular Cancer Therapeutics. 12: 3-15. PMID 23112250 DOI: 10.1158/1535-7163.MCT-12-0492  1
2012 Singh S, Sharma A, Robertson GP. Realizing the clinical potential of cancer nanotechnology by minimizing toxicologic and targeted delivery concerns. Cancer Research. 72: 5663-8. PMID 23139207 DOI: 10.1158/0008-5472.CAN-12-1527  1
2012 Madhunapantula SV, Robertson GP. Chemoprevention of melanoma. Advances in Pharmacology (San Diego, Calif.). 65: 361-98. PMID 22959032 DOI: 10.1016/B978-0-12-397927-8.00012-9  1
2012 Gowda R, Madhunapantula SV, Desai D, Amin S, Robertson GP. Selenium-containing histone deacetylase inhibitors for melanoma management. Cancer Biology & Therapy. 13: 756-65. PMID 22669577 DOI: 10.4161/cbt.20558  1
2012 Madhunapantula SV, Hengst J, Gowda R, Fox TE, Yun JK, Robertson GP. Targeting sphingosine kinase-1 to inhibit melanoma. Pigment Cell & Melanoma Research. 25: 259-74. PMID 22236408 DOI: 10.1111/j.1755-148X.2012.00970.x  1
2012 Sharma A, Madhunapantula SV, Robertson GP. Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems. Expert Opinion On Drug Metabolism & Toxicology. 8: 47-69. PMID 22097965 DOI: 10.1517/17425255.2012.637916  1
2011 Madhunapantula SV, Mosca PJ, Robertson GP. The Akt signaling pathway: an emerging therapeutic target in malignant melanoma. Cancer Biology & Therapy. 12: 1032-49. PMID 22157148 DOI: 10.4161/cbt.12.12.18442  1
2011 Sudol M, Fritz JL, Tran M, Robertson GP, Ealy JB, Katzman M. Evaluation of a system to screen for stimulators of non-specific DNA nicking by HIV-1 integrase: application to a library of 50,000 compounds. Antiviral Chemistry & Chemotherapy. 22: 67-74. PMID 21984686 DOI: 10.3851/IMP1857  1
2011 Madhunapantula SV, Robertson GP. Therapeutic Implications of Targeting AKT Signaling in Melanoma. Enzyme Research. 2011: 327923. PMID 21461351 DOI: 10.4061/2011/327923  1
2011 Chung CY, Madhunapantula SV, Desai D, Amin S, Robertson GP. Melanoma prevention using topical PBISe. Cancer Prevention Research (Philadelphia, Pa.). 4: 935-48. PMID 21367959 DOI: 10.1158/1940-6207.CAPR-10-0202  1
2011 Cheng Y, Ren X, Zhang Y, Patel R, Sharma A, Wu H, Robertson GP, Yan L, Rubin E, Yang JM. eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206. Cancer Research. 71: 2654-63. PMID 21307130 DOI: 10.1158/0008-5472.CAN-10-2889  1
2011 Mosca PJ, Robertson GP. Augmentation of tumor-specific immunity by upregulation of apoptotic melanoma cell calreticulin expression. Cancer Biology & Therapy. 11: 581-3. PMID 21282973 DOI: 10.4161/cbt.11.6.14697  1
2011 Zhang P, Ozdemir T, Chung CY, Robertson GP, Dong C. Sequential binding of αVβ3 and ICAM-1 determines fibrin-mediated melanoma capture and stable adhesion to CD11b/CD18 on neutrophils. Journal of Immunology (Baltimore, Md. : 1950). 186: 242-54. PMID 21135163 DOI: 10.4049/jimmunol.1000494  1
2011 Nguyen N, Sharma A, Nguyen N, Sharma AK, Desai D, Huh SJ, Amin S, Meyers C, Robertson GP. Melanoma chemoprevention in skin reconstructs and mouse xenografts using isoselenocyanate-4. Cancer Prevention Research (Philadelphia, Pa.). 4: 248-58. PMID 21097713 DOI: 10.1158/1940-6207.CAPR-10-0106  1
2010 Madhunapantula SV, Gowda R, Inamdar GS, Robertson GP. In situ photoimmunotherapy: a new hope for cutaneous melanoma patients. Cancer Biology & Therapy. 10: 1088-90. PMID 21178399 DOI: 10.4161/cbt.10.11.13663  1
2010 Madhunapantula SV, Mosca P, Robertson GP. Steroid hormones drive cancer development. Cancer Biology & Therapy. 10: 765-6. PMID 20935464 DOI: 10.4161/cbt.10.8.13531  1
2010 Huh SJ, Chen YL, Friedman SL, Liao J, Huang HJ, Cavenee WK, Robertson GP. KLF6 Gene and early melanoma development in a collagen I-rich extracellular environment. Journal of the National Cancer Institute. 102: 1131-47. PMID 20660366 DOI: 10.1093/jnci/djq218  1
2010 Huh SJ, Liang S, Sharma A, Dong C, Robertson GP. Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development. Cancer Research. 70: 6071-82. PMID 20610626 DOI: 10.1158/0008-5472.CAN-09-4442  1
2010 Inamdar GS, Madhunapantula SV, Robertson GP. Targeting the MAPK pathway in melanoma: why some approaches succeed and other fail. Biochemical Pharmacology. 80: 624-37. PMID 20450891 DOI: 10.1016/j.bcp.2010.04.029  1
2010 Huh SJ, Chung CY, Sharma A, Robertson GP. Macrophage inhibitory cytokine-1 regulates melanoma vascular development. The American Journal of Pathology. 176: 2948-57. PMID 20431030 DOI: 10.2353/ajpath.2010.090963  1
2010 Mathew R, Jia W, Sharma A, Zhao Y, Clarke LE, Cheng X, Wang H, Salli U, Vrana KE, Robertson GP, Zhu J, Wang S. Robust activation of the human but not mouse telomerase gene during the induction of pluripotency. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 2702-15. PMID 20354136 DOI: 10.1096/fj.09-148973  1
2010 Desai D, Madhunapantula SV, Gowdahalli K, Sharma A, Chandagaludoreswamy R, El-Bayoumy K, Robertson GP, Amin S. Synthesis and characterization of a novel iNOS/Akt inhibitor Se,Se'-1,4-phenylenebis(1,2-ethanediyl)bisisoselenourea (PBISe)--against colon cancer. Bioorganic & Medicinal Chemistry Letters. 20: 2038-43. PMID 20153642 DOI: 10.1016/j.bmcl.2009.09.071  1
2010 Sudol M, Tran M, Nowak MG, Flanagan JM, Robertson GP, Katzman M. A nonradioactive plate-based assay for stimulators of nonspecific DNA nicking by HIV-1 integrase and other nucleases. Analytical Biochemistry. 396: 223-30. PMID 19748478 DOI: 10.1016/j.ab.2009.09.012  1
2009 Mounir Z, Krishnamoorthy JL, Robertson GP, Scheuner D, Kaufman RJ, Georgescu MM, Koromilas AE. Tumor suppression by PTEN requires the activation of the PKR-eIF2alpha phosphorylation pathway. Science Signaling. 2: ra85. PMID 20029030 DOI: 10.1126/scisignal.2000389  1
2009 Tran MA, Watts RJ, Robertson GP. Use of liposomes as drug delivery vehicles for treatment of melanoma. Pigment Cell & Melanoma Research. 22: 388-99. PMID 19493316 DOI: 10.1111/j.1755-148X.2009.00581.x  1
2009 Madhunapantula SV, Robertson GP. The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma. Pigment Cell & Melanoma Research. 22: 400-19. PMID 19493313 DOI: 10.1111/j.1755-148X.2009.00585.x  1
2009 Sharma A, Sharma AK, Madhunapantula SV, Desai D, Huh SJ, Mosca P, Amin S, Robertson GP. Targeting Akt3 signaling in malignant melanoma using isoselenocyanates. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 1674-85. PMID 19208796 DOI: 10.1158/1078-0432.CCR-08-2214  1
2009 Salli U, Fox TE, Carkaci-Salli N, Sharma A, Robertson GP, Kester M, Vrana KE. Propagation of undifferentiated human embryonic stem cells with nano-liposomal ceramide. Stem Cells and Development. 18: 55-65. PMID 18393629 DOI: 10.1089/scd.2007.0271  1
2008 Kester M, Heakal Y, Fox T, Sharma A, Robertson GP, Morgan TT, AltinoÄŸlu EI, Tabaković A, Parette MR, Rouse SM, Ruiz-Velasco V, Adair JH. Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells. Nano Letters. 8: 4116-21. PMID 19367878 DOI: 10.1021/nl802098g  1
2008 Sharma AK, Sharma A, Desai D, Madhunapantula SV, Huh SJ, Robertson GP, Amin S. Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates. Journal of Medicinal Chemistry. 51: 7820-6. PMID 19053750 DOI: 10.1021/jm800993r  1
2008 Tran MA, Gowda R, Sharma A, Park EJ, Adair J, Kester M, Smith NB, Robertson GP. Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development. Cancer Research. 68: 7638-49. PMID 18794153 DOI: 10.1158/0008-5472.CAN-07-6614  1
2008 Tran MA, Smith CD, Kester M, Robertson GP. Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 3571-81. PMID 18519791 DOI: 10.1158/1078-0432.CCR-07-4881  1
2008 Madhunapantula SV, Desai D, Sharma A, Huh SJ, Amin S, Robertson GP. PBISe, a novel selenium-containing drug for the treatment of malignant melanoma. Molecular Cancer Therapeutics. 7: 1297-308. PMID 18483317 DOI: 10.1158/1535-7163.MCT-07-2267  1
2008 Cheung M, Sharma A, Madhunapantula SV, Robertson GP. Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development. Cancer Research. 68: 3429-39. PMID 18451171 DOI: 10.1158/0008-5472.CAN-07-5867  1
2008 Madhunapantula SV, Robertson GP. Is B-Raf a good therapeutic target for melanoma and other malignancies? Cancer Research. 68: 5-8. PMID 18172288 DOI: 10.1158/0008-5472.CAN-07-2038  1
2008 Girroir EE, Hollingshead HE, Billin AN, Willson TM, Robertson GP, Sharma AK, Amin S, Gonzalez FJ, Peters JM. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines. Toxicology. 243: 236-43. PMID 18054822 DOI: 10.1016/j.tox.2007.10.023  1
2008 Lung HL, Lo CC, Wong CC, Cheung AK, Cheong KF, Wong N, Kwong FM, Chan KC, Law EW, Tsao SW, Chua D, Sham JS, Cheng Y, Stanbridge EJ, Robertson GP, et al. Identification of tumor suppressive activity by irradiation microcell-mediated chromosome transfer and involvement of alpha B-crystallin in nasopharyngeal carcinoma. International Journal of Cancer. Journal International Du Cancer. 122: 1288-96. PMID 18027848 DOI: 10.1002/ijc.23259  1
2007 Sharma A, Robertson GP. Models of melanoma metastasis: using a transient siRNA-based protein inhibition strategy in mice to validate the functional relevance of pharmacological agents. Current Protocols in Pharmacology / Editorial Board, S.J. Enna (Editor-in-Chief) ... [Et Al.]. Unit 14.6. PMID 21948165 DOI: 10.1002/0471141755.ph1406s38  1
2007 Robertson GP. Mig-7 linked to vasculogenic mimicry. The American Journal of Pathology. 170: 1454-6. PMID 17456752 DOI: 10.2353/ajpath.2007.070127  1
2007 Madhunapantula SV, Sharma A, Robertson GP. PRAS40 deregulates apoptosis in malignant melanoma. Cancer Research. 67: 3626-36. PMID 17440074 DOI: 10.1158/0008-5472.CAN-06-4234  1
2006 Sharma A, Tran MA, Liang S, Sharma AK, Amin S, Smith CD, Dong C, Robertson GP. Targeting mitogen-activated protein kinase/extracellular signal-regulated kinase kinase in the mutant (V600E) B-Raf signaling cascade effectively inhibits melanoma lung metastases. Cancer Research. 66: 8200-9. PMID 16912199 DOI: 10.1158/0008-5472.CAN-06-0809  1
2006 Karbowniczek M, Robertson GP, Henske EP. Rheb inhibits C-raf activity and B-raf/C-raf heterodimerization. The Journal of Biological Chemistry. 281: 25447-56. PMID 16803888 DOI: 10.1074/jbc.M605273200  1
2005 Croushore JA, Blasiole B, Riddle RC, Thisse C, Thisse B, Canfield VA, Robertson GP, Cheng KC, Levenson R. Ptena and ptenb genes play distinct roles in zebrafish embryogenesis. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 234: 911-21. PMID 16193492 DOI: 10.1002/dvdy.20576  1
2005 Stover TC, Sharma A, Robertson GP, Kester M. Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 3465-74. PMID 15867249 DOI: 10.1158/1078-0432.CCR-04-1770  1
2005 Sharma A, Trivedi NR, Zimmerman MA, Tuveson DA, Smith CD, Robertson GP. Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors. Cancer Research. 65: 2412-21. PMID 15781657 DOI: 10.1158/0008-5472.CAN-04-2423  1
2004 Miller CJ, Cheung M, Sharma A, Clarke L, Helm K, Mauger D, Robertson GP. Method of mutation analysis may contribute to discrepancies in reports of (V599E)BRAF mutation frequencies in melanocytic neoplasms. The Journal of Investigative Dermatology. 123: 990-2. PMID 15482489 DOI: 10.1111/j.0022-202X.2004.23468.x  1
2004 Stahl JM, Sharma A, Cheung M, Zimmerman M, Cheng JQ, Bosenberg MW, Kester M, Sandirasegarane L, Robertson GP. Deregulated Akt3 activity promotes development of malignant melanoma. Cancer Research. 64: 7002-10. PMID 15466193 DOI: 10.1158/0008-5472.CAN-04-1399  1
2004 Karbowniczek M, Cash T, Cheung M, Robertson GP, Astrinidis A, Henske EP. Regulation of B-Raf kinase activity by tuberin and Rheb is mammalian target of rapamycin (mTOR)-independent. The Journal of Biological Chemistry. 279: 29930-7. PMID 15150271 DOI: 10.1074/jbc.M402591200  1
2003 Hingorani SR, Jacobetz MA, Robertson GP, Herlyn M, Tuveson DA. Suppression of BRAF(V599E) in human melanoma abrogates transformation. Cancer Research. 63: 5198-202. PMID 14500344  1
2003 Stahl JM, Cheung M, Sharma A, Trivedi NR, Shanmugam S, Robertson GP. Loss of PTEN promotes tumor development in malignant melanoma. Cancer Research. 63: 2881-90. PMID 12782594  1
2003 Robertson GP, Sargent L, Nelson MA. Positional approaches to cancer genetics. Methods in Molecular Biology (Clifton, N.J.). 222: 339-64. PMID 12710697 DOI: 10.1385/1-59259-328-3:339  1
Show low-probability matches.